Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pousset

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
International Journal of Cardiology|February 16, 2021
Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxiaL Legrand, C Heuze, A Diallo, et al.
The American Journal of Cardiology|March 15, 1996
Effects of bisoprolol on heart rate variability in heart failureF Pousset, X Copie, P Lechat, et al.
The Journal of Endocrinology|January 1, 1996
Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failureC Azizi, G Maistre, H Kalotka, et al.
International Journal of Cardiology|January 31, 2014
Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial studyE Gandjbakhch, V Fressart, G Duthoit, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Leukemia|October 20, 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa groupA-L Taksin, O Legrand, E Raffoux, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
International Journal of Cardiology|February 16, 2021
Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxiaL Legrand, C Heuze, A Diallo, et al.
The American Journal of Cardiology|March 15, 1996
Effects of bisoprolol on heart rate variability in heart failureF Pousset, X Copie, P Lechat, et al.
The Journal of Endocrinology|January 1, 1996
Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failureC Azizi, G Maistre, H Kalotka, et al.
International Journal of Cardiology|January 31, 2014
Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial studyE Gandjbakhch, V Fressart, G Duthoit, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Leukemia|October 20, 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa groupA-L Taksin, O Legrand, E Raffoux, et al.
Pageof 5